Related Experiment Video
Updated: Jun 26, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
Four cases of arthritis associated with Mycoplasma pneumoniae infection
Kohji Azumagawa1, Yukiko Kambara, Takuji Murata
1Department of Pediatrics, Seikeikai Hospital, Osaka, Japan. hyp53232@mopera.net [corrected]
Background:
Mycoplasma pneumoniae infection is diagnosed commonly by marked elevation of serum antibodies, but this requires several days and consequently M. pneumoniae infection might be overlooked in some cases. Recently an ImmunoCard Mycoplasma rapid diagnosis test (IC) has been developed and used clinically. One of the advantages of this diagnosis test is that clinicians can recognize the infection by a single administration at the beginning of treatment.
Methods:
A total of 1033 children aged 1-15 years (average 2.0 years) were examined. The diagnosis of M. pneumoniae infection was made mainly on the basis of a positive reaction to the IC. Also where possible, particle agglutination (PA) was performed as a confirmatory test. Diagnosis was made on the basis of a fourfold or greater rise in the PA antibody titer by paired sera or an initial single PA titer >1:320. Arthritis was diagnosed mainly on clinical symptoms. Additionally, ultrasonography (US) was conducted to confirm arthritis. In using US, arthritis was defined as an enlargement of the low echoic section or fluid retention inside the articular capsule.
Results:
IC was used in 1033 patients and results were positive in 348 (33.6%). Of these 348, there were 70 cases of pneumonia (20.1%) and four cases of arthritis (1.1%). IC was positive in all of the cases of arthritis, and in two of the four arthritis patients the PA titers were also useful for diagnoses. In three of four cases, US was performed and lesions were observed in two of three cases. Three of the four arthritis patients were infants and only one of these three had pneumonia.
Conclusions:
Using IC as a screening test, occult M. pneumoniae infections were discovered that would otherwise have been overlooked. These included two patients with US-proved arthritis. Arthritis in the absence of pneumonia may not be an unusual manifestation in infants infected by this organism.
Insights
A rapid diagnostic test for Mycoplasma pneumoniae infection aids in early detection, identifying cases, including those with arthritis, that traditional antibody tests might miss. This rapid diagnosis is crucial for timely treatment and understanding atypical presentations in children.
Area of Science:
- Pediatrics
- Infectious Diseases
- Diagnostic Medicine
Background:
- Traditional Mycoplasma pneumoniae diagnosis relies on antibody titers, which are time-consuming and may delay treatment.
- A rapid ImmunoCard Mycoplasma test (IC) offers a faster diagnostic approach, enabling early detection at the start of treatment.
Observation:
- A study involving 1033 children (aged 1-15 years) utilized the IC test for Mycoplasma pneumoniae diagnosis.
- The IC test identified 33.6% of children as positive, with 20.1% having pneumonia and 1.1% presenting with arthritis.
Findings:
- The IC test detected all four cases of arthritis, with two cases confirmed by ultrasonography (US).
- Notably, arthritis occurred in infants without pneumonia, suggesting this as a potential manifestation of Mycoplasma pneumoniae infection.
Implications:
- The IC test effectively identifies occult Mycoplasma pneumoniae infections, including those presenting with arthritis.
- Arthritis in infants may be an underrecognized symptom of Mycoplasma pneumoniae infection, highlighting the importance of rapid diagnostics.
Related Concept Videos
Atypical Pneumonia
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: